G-FACTOR
G-Factor is a reactive environment whose aim is to support new entrepreneurs and researchers with high entrepreneurial potential to become companies able to successfully establish themselves in the market, creating replicable and scalable models. Three years after its establishment, G-Factor has consolidated its position as an accelerator for start-ups in the life sciences sector, while opening up to other vertical sectors.
We invest in innovative start-ups and teams by providing capital and expertise because we believe that the mix of finance and training is crucial to entrepreneurial success.
I-Tech Innovation Program 2022 Download report 2022
I-Tech Innovation 2022 is the second edition of the program promoted by Fondazione Golinelli and CRIF. The project is based on 3 Calls for Innovation in the Life Science & Digital Health, FinTech & InsurTech and AgriTech & FoodTech segments. Besides, this year’s edition adds 2 Calls for Plug In in two disruptive areas Industry 4.0, Big Data processing-HPC & Applied Artificial Intelligence (in partnership with Competence Center Bi-Rex) and Social Impact (in partnership with Emil Banca e Gruppo BCC ICCREA).
Subscriptions to the call were open until june 2022 to researchers, independent teams, and startups whith the goal to turn their projects into efficient business models and entities. The selected teams will be granted access to G-Force 2022, the acceleration customized program that offers investments, mentoring meetings and business networking opportunities.
This year’s investment consists of 1.500.000 €, that will be divided among the 10 startups’ batch composed of:
- 3 startups of the Life Science & Digital Health sectors
- 2 startups of the FinTech & InsurTech sectors
- 1 startups of the AgriTech & FoodTech sectors
- 2 startups of the Industry 4.0, Big Data processing-HPC & Applied Artificial Intelligence sectors
- 2 startups of the Social Impact sector
G-FORCE
G-Factor's acceleration program renews its formula in a tailored way, aimed to the I-Tech Innovation Program 2022 startups. Its teams will have access to an innovative acceleration program for young talents that will allow them to grow both in an entrepreneurial and scientific way. G-Force consists of 4 months: the first 2 months are based on intensive activities, which at least two residential weeks are part of. The selected teams will learn how to engage potential industrial partners. This first phase will be followed by 2 months of remote follow-up mentoring activities dedicated to execution. The startups, thanks to tailored meetings and specific training, will learn how to introduce themselves to potential investors and take the following steps for growth and development. The residential activities will mainly take place at BOOM, the new innovation center promoted by CRIF, and also in the G-Factor incubator-accelerator at Opificio Golinelli.
SERVICES & FACILITIES
- Access to a network of highly qualified mentors and partners
- Access to a network of investors
- Legal and patent support
- Regulatory advice
- Media Coverage & Communications

JOIN THE STARTUP COMMUNITY
"Startup Community" is the new community dedicated to startups promoted by CRIF and G-Factor. The shared goal is to give startups the opportunity to take part in one-to-one meetings with investors and in webinars with international professionals from the world of business, finance and research.
EXPERT FOR YOU! THE NEW STARTUP COMMUNITY OFFER
Expert for You! is the new Startup Community initiative, a catalog of webinars, on several topics, in which:
- meetings are held by G-Factor expert mentors, selected on the basis of their skills and knowledge of the startup ecosystem;
- each meeting is open to a maximum of 10 participants, to give everyone the opportunity to discuss about his own startup;
Want to know more about the mentors and webinars?
Upcoming G-Factor Events
Network
We collaborate with dozens of entrepreneurs, teachers and managers with different specializations and professional backgrounds to cover all the needs of accelerated startups: from product development to business storytelling, from IP to negotiation, from hard skills to soft skills.
Our industrial partners are important international players in the world of life sciences operating in different business areas: from pharmaceutical to medical devices, from biotech to data science. Together with our industrial partners we help startups to create sustainable and scalable businesses.
Our network is enriched by the presence of research centers, startups, companies and universities that make innovation their daily mission.
We work together with some of the main Italian institutions to accompany our startups on their growth path.
Startups
124 applications have been received for the first call of G-Factor, Life Sciences Innovation : 30 of these have reached the final stage and 10 have been selected to participate in the acceleration process which has end in December 2019 with the awaited Investor Day. Each Startup has received an investment of €100,000 €


BCI deals with the biocompatibility of cardiac valve substitutes manufactured with animal tissues, improving their performance and doubling their durability.


Adam's Hand is a myoelectric hand prosthesis. A single motor allows you to move all your fingers, automatically adapting them to the shape and size of the objects being handled


Complexdata has developed a platform that uses artificial intelligence to estimate the risk of metastasis in cancer patients.


Diamante specializes in the production of nanoparticles for the diagnosis of autoimmune diseases through the exploitation of plants as compounds with high added value.


eVAI is cloud platform developed by enGenome to support geneticists in the diagnosis of hereditary diseases from NGS data.


Genoa Instruments, will produce high-tech scientific instruments in the field of super-resolution optical microscopy.


Holey has created a solution capable of producing custom-made 3D printable orthopedic braces, which can replace both traditional plaster and commercial braces.


MgShell developed a solution to treat maculopathy capable of timing the drug release, therefore reducing the therapeutic load from several injections to a single injection.


P4P produces innovative polymeric biomaterials processed with additive manufacturing techniques to obtain advanced systems for the personalized administration of drugs.


RELIEF has created a minimally invasive endourethral device that can be inserted into the urethra of patients with severe incontinence and can be activated with a small magnet.
137 applications have been received for the second call of G-Factor, Life Sciences Innovation 2020: 24 of these have reached the final stage and 5 have been selected to participate in the acceleration process which will end in December 2020 with the awaited Investor Day. Each Startup will receive an investment of €125,000 of which € 90,000 of liquidity and € 35,000 in kinds.


Thanks to a patented biotechnology, Bacfarm produces deinoxanthin, the most powerful antioxidant among carotenoids and UV shield.


Innovative and unique CTC single cell blood analysis, disposable microfluidic analysis device, single cell analysis, image sorting and archiving.


An innovative biosensor for prostate cancer to reduce the number of unnecessary tests, costs, waiting times and inconvenience for the patient.


Micro-ReSkin is a PerFormS product developed to meet the needs of patients with acute, or chronic skin inflammations such as psoriasis.


RECORNEA has developed a revolutionary solution. With a single device and in a single step it managed to improve her eyesight and stop the progression of the keratoconus.
209 applications received for the I-Tech Innovation Program call launched by Fondazione Golinelli and CRIF in three areas: Life Sciences/Digital Health (3 startups selected), Fintech/Insurtech (2 startups selected), and FoodTech/Agritech (2 startups selected). 1 million euros will be granted for the startups themselves


created with the aim of experimenting a new compound called DDC#1 on humans for Acute Myeloid Leukemia and COVID-19 fighting


goes to market through a device that makes the medicines’ selection process faster and more effective through the laboratory plastic creation of an environment that looks like the tissues of the human body and indeed similar to the context in which the medicine will work


is based on the use of polymeric retinal prostheses for vision recovery, subsequent to a loss due to retinal degeneration induced by several diseases (i.e. retinitis pigmentosa).


EvenFi is the crowdlending platform that offers investors the opportunity to earn by investing in growth projects of startups and SMEs.


allows consumers to choose and select the innovative financial services that best comply with their needs. Its services let suppliers access a single distribution channel that guarantees them to contain acquisition costs.


is the first virtual agricultural community based on two pillars: small producers and final consumers. It is also a marketplace for direct sales of agricultural products.


is a unified data analysis platform that is fully automated and able to extract information from satellite images. By removing the technological barriers in the use of satellite data, the platform allows to transform satellite images into geospatial information by offering data the farmer needs in the simplest way to read them.
247 applications received for the I-Tech Innovation Program call launched by Fondazione Golinelli and CRIF in five areas: Life Sciences/Digital Health (3 startups selected), Fintech/Insurtech (2 startups selected), FoodTech/Agritech (1 startups selected), Industry 4.0 (2 startups selected) and Social Impact (2 startups selected). 1,5 million euros has been invested for the startups.


AEQUIP, a startup and spin-off of the Politecnico di Torino, develops diagnostic support tools in the field of Digital Pathology, which integrate Artificial Intelligence with mathematical-statistical parameters in a new proprietary approach called MDI: Mathematical Driven Intelligence.


Docunque is a medical practice management software that helps doctors in their daily work, improving prescriptive appropriateness and acting on citizen prevention, using artificial intelligence algorithms. Docunque innovates from the bottom up by intervening in what is often the only professional tool that doctors use every day.


UCme Bioscience is developing a new anti-angiogenic antibody of its own invention for the therapy of diseases with a neovascular component, such as diabetic retinopathy and age-related macular degeneration, for which the treatments currently used do not lead to a complete and lasting cure. Since angiogenesis is also involved in the development of cancer, important applications of the product are also expected in this field.


Agrobit develops and sells innovative services and apps for digital farming. The app iAgro allows the farmer to transform his smartphone into a decision support system to map tree crops and optimize phytosanitary treatments, in a simple and scalable way. The service of remote sensing by drones provides the farmer with a complete mapping of his fields and crops in order to optimize the use of fertilizers, agrochemicals and water.


Mopso is a regtech company that develops two software to deal with anti-money laundering regulations, Brain and Amlet. Brain is a risk assessment tool and helps banks find suspicious transactions. Amlet makes due diligence data 'portable' and reusable within an ecosystem of intermediaries, simplifying the onboarding process. Mopso can handle all the complexities within the financial world, as they use the largest and most sophisticated ontology, FIBO (Financial Industry Business Ontology), together with AML ontology.


Notarify solve several problems and risks related to the storage, sharing and signing of files. Notarify, in fact, is the first platform for the management of the entire lifecycle of documents with Blockchain validation, i.e. the so-called 'notarization', which allows to obtain a certain date and a proof of immutability of the content.


AdapTronics makes logistics more sustainable on Earth and in Space by reinventing how robots grasp objects of any shape, size and material thanks to a proprietary thin-film technology that becomes adhesive when electrically activated, with an impressive force density, irrelevant weight and minimal energy consumption.


Astreo is an innovative startup that deals with Industrial Internet of Things (IIoT). Through Astreo products it is possible to extract data from machinery and use them, through AI algorithms, for production control, for the reduction of energy consumption and for predictive maintenance. It uses state-of-the-art technologies that allow Industry 4.0 solutions to be created in an easy and non-invasive way.


Heaple is developing a telemedicine platform that offers an innovative solution for cognitive therapy. Thanks to its patient app, Heaple offers personalised and ongoing digital therapy that helps maintain cognitive benefits for longer, with cost savings and reduced number of visits to the clinic. The web dashboard for the doctor, instead, allows to better plan and analyze the course of therapy, using artificial intelligence algorithms to support him in the management of the therapy cycle.


Justep is a medical device that aims to replace the white cane for the blind and visually impaired and to solve the problem of navigation. Justep thanks to its artificial intelligence works with a lidar sensor and a camera that detect and recognize any obstacle in front of the user, suggesting the best path to reach his/her destination.


BCI deals with the biocompatibility of cardiac valve substitutes manufactured with animal tissues, improving their performance and doubling their durability.


Adam's Hand is a myoelectric hand prosthesis. A single motor allows you to move all your fingers, automatically adapting them to the shape and size of the objects being handled


Complexdata has developed a platform that uses artificial intelligence to estimate the risk of metastasis in cancer patients.


Diamante specializes in the production of nanoparticles for the diagnosis of autoimmune diseases through the exploitation of plants as compounds with high added value.


eVAI is cloud platform developed by enGenome to support geneticists in the diagnosis of hereditary diseases from NGS data.


Genoa Instruments, will produce high-tech scientific instruments in the field of super-resolution optical microscopy.


Holey has created a solution capable of producing custom-made 3D printable orthopedic braces, which can replace both traditional plaster and commercial braces.


MgShell developed a solution to treat maculopathy capable of timing the drug release, therefore reducing the therapeutic load from several injections to a single injection.


P4P produces innovative polymeric biomaterials processed with additive manufacturing techniques to obtain advanced systems for the personalized administration of drugs.


RELIEF has created a minimally invasive endourethral device that can be inserted into the urethra of patients with severe incontinence and can be activated with a small magnet.


Thanks to a patented biotechnology, Bacfarm produces deinoxanthin, the most powerful antioxidant among carotenoids and UV shield.


Innovative and unique CTC single cell blood analysis, disposable microfluidic analysis device, single cell analysis, image sorting and archiving.


An innovative biosensor for prostate cancer to reduce the number of unnecessary tests, costs, waiting times and inconvenience for the patient.


Micro-ReSkin is a PerFormS product developed to meet the needs of patients with acute, or chronic skin inflammations such as psoriasis.


RECORNEA has developed a revolutionary solution. With a single device and in a single step it managed to improve her eyesight and stop the progression of the keratoconus.


created with the aim of experimenting a new compound called DDC#1 on humans for Acute Myeloid Leukemia and COVID-19 fighting


goes to market through a device that makes the medicines’ selection process faster and more effective through the laboratory plastic creation of an environment that looks like the tissues of the human body and indeed similar to the context in which the medicine will work


is based on the use of polymeric retinal prostheses for vision recovery, subsequent to a loss due to retinal degeneration induced by several diseases (i.e. retinitis pigmentosa).


EvenFi is the crowdlending platform that offers investors the opportunity to earn by investing in growth projects of startups and SMEs.


allows consumers to choose and select the innovative financial services that best comply with their needs. Its services let suppliers access a single distribution channel that guarantees them to contain acquisition costs.


is the first virtual agricultural community based on two pillars: small producers and final consumers. It is also a marketplace for direct sales of agricultural products.


is a unified data analysis platform that is fully automated and able to extract information from satellite images. By removing the technological barriers in the use of satellite data, the platform allows to transform satellite images into geospatial information by offering data the farmer needs in the simplest way to read them.


AEQUIP, a startup and spin-off of the Politecnico di Torino, develops diagnostic support tools in the field of Digital Pathology, which integrate Artificial Intelligence with mathematical-statistical parameters in a new proprietary approach called MDI: Mathematical Driven Intelligence.


Docunque is a medical practice management software that helps doctors in their daily work, improving prescriptive appropriateness and acting on citizen prevention, using artificial intelligence algorithms. Docunque innovates from the bottom up by intervening in what is often the only professional tool that doctors use every day.


UCme Bioscience is developing a new anti-angiogenic antibody of its own invention for the therapy of diseases with a neovascular component, such as diabetic retinopathy and age-related macular degeneration, for which the treatments currently used do not lead to a complete and lasting cure. Since angiogenesis is also involved in the development of cancer, important applications of the product are also expected in this field.


Agrobit develops and sells innovative services and apps for digital farming. The app iAgro allows the farmer to transform his smartphone into a decision support system to map tree crops and optimize phytosanitary treatments, in a simple and scalable way. The service of remote sensing by drones provides the farmer with a complete mapping of his fields and crops in order to optimize the use of fertilizers, agrochemicals and water.


Mopso is a regtech company that develops two software to deal with anti-money laundering regulations, Brain and Amlet. Brain is a risk assessment tool and helps banks find suspicious transactions. Amlet makes due diligence data 'portable' and reusable within an ecosystem of intermediaries, simplifying the onboarding process. Mopso can handle all the complexities within the financial world, as they use the largest and most sophisticated ontology, FIBO (Financial Industry Business Ontology), together with AML ontology.


Notarify solve several problems and risks related to the storage, sharing and signing of files. Notarify, in fact, is the first platform for the management of the entire lifecycle of documents with Blockchain validation, i.e. the so-called 'notarization', which allows to obtain a certain date and a proof of immutability of the content.


AdapTronics makes logistics more sustainable on Earth and in Space by reinventing how robots grasp objects of any shape, size and material thanks to a proprietary thin-film technology that becomes adhesive when electrically activated, with an impressive force density, irrelevant weight and minimal energy consumption.


Astreo is an innovative startup that deals with Industrial Internet of Things (IIoT). Through Astreo products it is possible to extract data from machinery and use them, through AI algorithms, for production control, for the reduction of energy consumption and for predictive maintenance. It uses state-of-the-art technologies that allow Industry 4.0 solutions to be created in an easy and non-invasive way.


Heaple is developing a telemedicine platform that offers an innovative solution for cognitive therapy. Thanks to its patient app, Heaple offers personalised and ongoing digital therapy that helps maintain cognitive benefits for longer, with cost savings and reduced number of visits to the clinic. The web dashboard for the doctor, instead, allows to better plan and analyze the course of therapy, using artificial intelligence algorithms to support him in the management of the therapy cycle.


Justep is a medical device that aims to replace the white cane for the blind and visually impaired and to solve the problem of navigation. Justep thanks to its artificial intelligence works with a lidar sensor and a camera that detect and recognize any obstacle in front of the user, suggesting the best path to reach his/her destination.
Team

Antonio Danieli
Vice President, General Manager and Board Member
@ Fondazione Golinelli
CEO @ G-Factor Incubator-Accelerator







BUSINESS AND SCIENTIFIC REFEREES
Contact Us
How can we help you?
Adress and VAT Number
Via Paolo Nanni Costa, 2040133 Bologna
VAT number 03710391206